FDA approves new test to detect HIV drug-resistance mutations
The Food and Drug Administration yesterday approved the first test to use next generation sequencing technology to detect HIV drug-resistance mutations in patients taking or about to start antiviral therapy. “The right combination of antivirals can lower viral loads, or the amount of virus in the blood stream, and help keep patients with HIV healthy for many years,” said Peter Marks, M.D., director of FDA’s Center for Biologics Evaluation and Research. “However, according to a recent report from the Centers for Disease Control and Prevention and the World Health Organization, the percentage of people living with HIV around the world that have resistance to some HIV drugs has increased from 11% to 29% since 2001.”
Related News Articles
Headline
The Department of Health and Human Services July 22 announced that it will participate in the Genesis Mission, an artificial intelligence initiative focusing…
Headline
Ryane Jackson, vice president of Community Health Network at Memorial Hermann Health System, explains how the system is creating seamless connections between…
Headline
The American Cancer Society released updated colorectal cancer screening guidelines May 27 that include the addition of a blood-based screening test to be…
Headline
The Centers for Disease Control and Prevention will host a webinar for clinicians May 28 at 2 p.m. ET on the ongoing Ebola outbreak in the Democratic…
Headline
The Centers for Disease Control and Prevention released a Health Alert Network Health Advisory May 8 notifying clinicians and health departments of the…
Headline
The Centers for Medicare & Medicaid Services April 13 announced that more than 150 organizations have been accepted to participate in the launch of its…